Afuco™ Anti-Pro108 ADCC Therapeutic Antibody, ADCC Enhanced

Anti-Pro108 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The specific antibodies to Pro108 can be used for assessing risk of prostate cancer and alleviating or treating an Pro108-expressing cancer in a mammal.
Supplier Creative Biolabs
Product # AFC-767CL
Pricing Inquiry
Type ADCC enhanced antibody
Storage 4°C or -20°C, avoid repeated freezing and thawing.
Host Humanized
Target Pro108
Feedback